Fibroblast growth factor 23 levels before and after renal transplantation
Background Fibroblast growth factor 23 (FGF23), a novel bone-derived hormone that inhibits phosphate reabsorption and calcitriol production by the kidney, has uncovered primary regulatory pathways and new systems biology governing bone mineralization, vitamin D metabolism, parathyroid gland function...
Saved in:
Main Authors: | Mohamed M El-khatib (Author), Amal R El-Shahaby (Author), Sahier O EEl-Khashab (Author), Eman El Mohamed (Author), Amr M Shaker (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of graft survival rates of renal transplants in Cairo University Hospitals
by: Mohamed G Saadi, et al.
Published: (2016) -
Renal transplantation experience in Cairo University hospitals
by: Mohammed G Saadi, et al.
Published: (2016) -
The significance of fibroblast growth factor-2 and kidney injury molecule-1 as biomarker of interstitial renal fibrosis in glomerulonephritis
by: Amr M. Shaker, et al.
Published: (2022) -
Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
by: Sahier O El-Khashab, et al.
Published: (2019) -
Il Fibroblast Growth Factor-23 (FGF-23)
by: D. Rendina, et al.
Published: (2018)